Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
15.09
Dollar change
-0.11
Percentage change
-0.72
%
IndexRUT P/E- EPS (ttm)-0.02 Insider Own0.68% Shs Outstand164.65M Perf Week-0.07%
Market Cap2.49B Forward P/E13.53 EPS next Y1.12 Insider Trans-7.88% Shs Float164.09M Perf Month-9.69%
Income-1.71M PEG- EPS next Q0.19 Inst Own97.83% Short Float7.30% Perf Quarter-42.75%
Sales813.81M P/S3.06 EPS this Y273.76% Inst Trans0.91% Short Ratio6.15 Perf Half Y-32.30%
Book/sh2.81 P/B5.36 EPS next Y73.52% ROA-0.23% Short Interest11.98M Perf Year-38.28%
Cash/sh2.85 P/C5.30 EPS next 5Y- ROE-0.41% 52W Range14.65 - 33.99 Perf YTD-51.80%
Dividend Est.- P/FCF39.16 EPS past 5Y28.03% ROI-0.33% 52W High-55.60% Beta0.40
Dividend TTM- Quick Ratio1.86 Sales past 5Y27.73% Gross Margin92.27% 52W Low3.00% ATR (14)0.60
Dividend Ex-Date- Current Ratio2.04 EPS Y/Y TTM98.70% Oper. Margin-0.56% RSI (14)36.69 Volatility3.94% 3.97%
Employees598 Debt/Eq0.13 Sales Y/Y TTM56.43% Profit Margin-0.21% Recom1.71 Target Price27.29
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q137.50% Payout- Rel Volume0.54 Prev Close15.20
Sales Surprise-1.19% EPS Surprise104.92% Sales Q/Q73.75% EarningsMay 08 AMC Avg Volume1.95M Price15.09
SMA20-5.26% SMA50-11.16% SMA200-34.87% Trades Volume1,059,047 Change-0.72%
Date Action Analyst Rating Change Price Target Change
Mar-12-24Reiterated Needham Buy $36 → $32
Mar-12-24Downgrade Mizuho Buy → Neutral $39 → $25
Jan-30-24Initiated Robert W. Baird Outperform $40
Jan-24-24Upgrade Needham Hold → Buy $37
Dec-19-23Upgrade Morgan Stanley Equal-Weight → Overweight $31 → $40
Dec-14-23Downgrade Deutsche Bank Buy → Hold $25
Dec-13-23Initiated Citigroup Buy $38
Dec-12-23Initiated Deutsche Bank Buy $25
Nov-06-23Upgrade Mizuho Neutral → Buy $20 → $35
Oct-17-23Initiated UBS Buy $33
May-17-24 04:05PM
May-15-24 09:05AM
May-10-24 01:15PM
11:20AM
10:01AM
04:58PM Loading…
May-09-24 04:58PM
03:29PM
11:07AM
05:59AM
03:37AM
May-08-24 08:57PM
05:15PM
04:15PM
04:05PM
May-04-24 02:27AM
10:01AM Loading…
May-01-24 10:01AM
Apr-30-24 12:17PM
Apr-29-24 04:16PM
Apr-24-24 04:05PM
Apr-22-24 09:04AM
Apr-20-24 09:15AM
Apr-19-24 04:05PM
Apr-17-24 04:05PM
Apr-11-24 02:10PM
Apr-10-24 01:28AM
Apr-02-24 04:05PM
Apr-01-24 04:05PM
Mar-28-24 11:30AM
02:00AM
Mar-20-24 01:31PM
04:05PM Loading…
Mar-15-24 04:05PM
Mar-14-24 06:49PM
Mar-13-24 04:05PM
Mar-12-24 04:08PM
03:05PM
11:06AM
09:30AM
07:43AM
Mar-11-24 04:46PM
04:13PM
04:05PM
Feb-29-24 09:05AM
08:44AM
Feb-28-24 04:05PM
09:12AM
Feb-27-24 05:20PM
04:56PM
04:27PM
04:05PM
Feb-22-24 08:16PM
Feb-21-24 04:05PM
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-08-24 01:15PM
Jan-30-24 08:48PM
05:00PM
Jan-26-24 05:31PM
Jan-25-24 08:42AM
Jan-19-24 04:05PM
Jan-18-24 04:05PM
Jan-12-24 05:02PM
Dec-21-23 04:05PM
Dec-18-23 04:05PM
Dec-13-23 09:24PM
04:14PM
01:41PM
Nov-30-23 09:05AM
Nov-27-23 09:05AM
Nov-21-23 11:03PM
05:00PM
Nov-17-23 09:40AM
Nov-16-23 08:42AM
Nov-14-23 04:12PM
Nov-08-23 05:24PM
Nov-04-23 01:10PM
Nov-02-23 06:51PM
04:37PM
04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-23-23 09:05AM
Oct-19-23 04:05PM
Oct-18-23 05:00PM
Oct-10-23 10:49AM
09:32AM
Oct-07-23 05:01AM
Sep-30-23 10:30AM
Sep-22-23 06:23PM
Sep-19-23 04:05PM
Aug-30-23 04:05PM
Aug-28-23 06:00PM
Aug-22-23 08:30AM
Aug-19-23 10:44AM
Aug-14-23 04:05PM
Aug-04-23 12:36PM
Aug-02-23 04:26PM
04:05PM
Aug-01-23 07:30PM
Jul-25-23 11:21AM
Jul-24-23 04:05PM
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAVIS STEPHENCEOMay 02 '24Sale16.9411,427193,573155,231May 03 06:00 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 02 '24Sale16.943,50359,34132,053May 03 06:00 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALMay 02 '24Sale16.943,47758,90042,133May 03 06:00 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 02 '24Sale16.941,32622,46214,370May 03 06:00 PM
DAVIS STEPHENCEOApr 08 '24Sale17.8726,574474,877144,267Apr 09 06:00 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 08 '24Sale17.872,71648,53528,742Apr 09 06:00 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALApr 08 '24Sale17.872,56845,89038,796Apr 09 06:00 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 08 '24Sale17.871,79031,98713,100Apr 09 06:00 PM
DAVIS STEPHENCEOMar 27 '24Sale17.9017,714317,081118,842Mar 27 07:58 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 27 '24Sale17.905,43497,26926,183Mar 27 07:57 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALMar 27 '24Sale17.905,14092,00636,340Mar 27 08:00 PM
DAVIS STEPHENCEOFeb 26 '24Sale24.675,577137,585101,890Feb 27 06:02 PM
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERFeb 26 '24Sale24.6777219,04521,067Feb 27 06:13 PM
Teehan BrendanEVP, COO, HEAD OF COMMERCIALFeb 26 '24Sale24.6762415,39431,432Feb 27 06:10 PM
Kihara JamesPRINCIPAL ACCOUNTING OFFICERFeb 26 '24Sale24.6747411,69411,391Feb 27 06:07 PM
DAVIS STEPHENCEOJan 08 '24Sale29.963,732111,81196,521Jan 09 06:00 PM
Teehan BrendanEVP, COO, Head of CommercialJan 08 '24Sale29.9673121,90130,949Jan 09 06:00 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryJan 08 '24Sale29.9659017,67646,901Jan 09 06:00 PM
Kihara JamesPrincipal Accounting OfficerDec 15 '23Sale28.302,00056,60011,025Dec 15 07:37 PM
Schneyer Mark C.EVP, Chief Financial OfficerNov 20 '23Sale22.645,108115,64520,486Nov 21 06:00 PM
Teehan BrendanEVP, COO, Head of CommercialNov 20 '23Sale22.644,960112,29430,393Nov 21 06:00 PM
Kihara JamesPrincipal Accounting OfficerNov 20 '23Sale22.641,98544,94013,025Nov 21 06:00 PM
DAVIS STEPHENCEOOct 06 '23Sale21.9651,5631,132,32389,131Oct 06 09:59 PM
KIM AUSTIN D.EVP,General Counsel, SecretaryOct 06 '23Sale21.9616,369359,46345,857Oct 06 10:00 PM
Kihara JamesPrincipal Accounting OfficerSep 15 '23Sale25.882,00051,76010,778Sep 19 06:31 PM
Schneyer Mark C.EVP, Chief Financial OfficerAug 21 '23Sale29.0010,000289,97015,682Aug 23 07:31 PM
DAVIS STEPHENCEOJul 14 '23Option Exercise20.77100,0002,077,000136,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 14 '23Sale30.04100,0003,004,35036,695Jul 18 06:00 PM
DAVIS STEPHENCEOJul 12 '23Sale25.0555,1041,380,44936,695Jul 13 08:27 PM
DAVIS STEPHENCEOJul 11 '23Sale25.0016,498412,45091,799Jul 13 08:27 PM
Kihara JamesPrincipal Accounting OfficerJun 15 '23Sale24.152,00048,3009,144Jun 16 04:38 PM
Brege LauraDirectorJun 12 '23Sale24.874,500111,90613,502Jun 14 05:14 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08 '23Option Exercise0.001,893023,798Jun 12 08:48 PM
Schneyer Mark C.EVP, Chief Financial OfficerJun 08 '23Sale25.0297424,36922,824Jun 12 08:48 PM